Select Page

Investor Information

At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.

Policies

Code of Conduct for Prohibition of Insider Trading

ODR Disclosure Policy

Details of Independent Directors’ Familiarization Program for 2023-24

Biodiversity Policy

Policy for determining Materiality of Events or Information

Details of Independent Directors’ Familiarization Program for 2022-23

Business Responsibility and Sustainability Policy

Suppliers Code of Conduct

Human Rights Policy

Role and Responsibilities of Lead Independent Director

Synopsis of Risk Management Policy

Board Diversity Policy

Tax Policy

Details of Independent Directors’ Familiarization Program for 2021-22

Corporate Social Responsibility Policy

Details of Independent Directors’ Familiarization Program for 2020-21

Details of Independent Directors’ Familiarization Program for 2019-20

Remuneration Policy

Policy on Material Subsidiaries

Details of Independent Directors Familiarization Programme 2018-19

Policy on Materiality of and Dealing with Related Party Transactions

Whistle Blower Policy for Sun Pharmaceutical Industries Limited & its Subsidiaries

Details of Independent Directors Familiarization Programme 2017-2018

Global Code of Conduct

SPIL Compliance Policy Effective 11-08-2017

Details of Independent Directors Familiarization Programme 2016-2017

Dividend Distribution Policy

Details of Independent Directors’ Familiarization Program for FY 2015-2016

Archival Policy

Code of Fair Disclosure

Details of Independent Directors Familiarisation Programme

Terms and conditions for Independent Director

Top